as I understand it.....it was a investigator initiated trial, that was allowed to occur based on phase 3 results of remestemcel-L to investigate extending the application from acute treatments to also include chronic treatments.
so I have no idea what phase level that is...not even going to pretend I do.
but "post-phase3", as I think they get a free pass as part of the extended access process?
i'm probably wrong, as don't have a full grasp ( and no way have I ever claimed to be a expert) ….but to me sounds promising to be alread exploring and having good results with extended applications.
@Doug Diamond if they could merge their success with CYP's manufacturing process.... would be a behemoth of a company then...be scary the end results...
- Forums
- ASX - By Stock
- CYP
- 2020 - A Year Full Of Potentials
2020 - A Year Full Of Potentials, page-245
-
- There are more pages in this discussion • 263 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CYP (ASX) to my watchlist
|
|||||
Last
25.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $44.90M |
Open | High | Low | Value | Volume |
25.5¢ | 26.0¢ | 24.5¢ | $19.72K | 78.84K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 31298 | 24.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.0¢ | 39430 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 31298 | 0.245 |
4 | 112215 | 0.240 |
2 | 119148 | 0.235 |
2 | 15173 | 0.230 |
1 | 20000 | 0.225 |
Price($) | Vol. | No. |
---|---|---|
0.250 | 39430 | 1 |
0.260 | 25384 | 1 |
0.290 | 1900 | 1 |
0.295 | 183892 | 1 |
0.300 | 85000 | 2 |
Last trade - 15.59pm 09/07/2024 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |